Evidence map›Paper›PMID 12819104›Full record

ArticleInfection and immunity2003

Nuclear factor kappa B protects against host cell apoptosis during Rickettsia rickettsii infection by inhibiting activation of apical and effector caspases and maintaining mitochondrial integrity.

Suresh G Joshi, Charles W Francis, David J Silverman, Sanjeev K Sahni

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Review
  3. Mitochondrial Dysfunction inTransboundary and emerging diseases · 2026
    Review
  4. Review
  5. Article
  6. Infection and immunity · 2025
    Article
  7. Apoptosis: A Key Process ThatJournal of parasitology research · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Lock and Key: WhyPathogens (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Macrophages Infected by a Pathogen and a Non-pathogen Spotted Fever GroupFrontiers in cellular and infection microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Suresh G JoshiHematology-Oncology Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.
Charles W Francis
David J Silverman
Sanjeev K Sahni
University of Rochester · USUniversity of Maryland, Baltimore · US

Funding

VON WILLEBRAND PROTEIN BIOSYNTHESIS AND STRUCTUREP01HL030616 · NHLBI · UNIVERSITY OF ROCHESTER · PI FRANCIS, CHARLES W. · 1985 to 2003
$6.5M
RICKETTSIA-INDUCED TRANSCRIPTIONAL ACTIVATIONR01AI040689 · NIAID · UNIVERSITY OF ROCHESTER · PI SAHNI, SANJEEV K. · 1997 to 2007
$2.0M
RICKETTSIA RICKETTSII IN HUMAN ENDOTHELIAL CELLSR01AI017416 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SILVERMAN, DAVID J · 1986 to 2002
$1.0M
Rickettsia-Induced Transcriptional ActivationR21AI040689 · NIAID · UNIVERSITY OF ROCHESTER · PI SAHNI, SANJEEV · 2002 to 2002
$347k
NHLBI NIH HHS HL 30616NHLBI NIH HHS P01 HL030616NIAID NIH HHS AI 17416NIAID NIH HHS AI 40689NIAID NIH HHS R01 AI040689NIAID NIH HHS R21 AI040689
6 · The paper itself

Abstract

Apoptotic host cell death is a critical determinant in the progression of microbial infections and outcome of resultant diseases. The potentially fatal human infection caused by Rickettsia rickettsii, the etiologic agent of Rocky Mountain spotted fever, involves the vascular endothelium of various organ systems of the host. Earlier studies have shown that survival of endothelial cells (EC) during this infection depends on their ability to activate the transcription factor nuclear factor kappa B (NF-kappa B). Here, we investigated the involvement of caspase cascades and associated signaling pathways in regulation of host cell apoptosis by NF-kappa B. Infection of cultured human EC with R. rickettsii with simultaneous inhibition of NF-kappa B induced the activation of apical caspases 8 and 9 and also the executioner enzyme, caspase 3, whereas infection alone had no significant effect. Inhibition of either caspase-8 or caspase-9 with specific cell-permeating peptide inhibitors caused a significant decline in the extent of apoptosis, confirming their importance. The peak caspase-3 activity occurred at 12 h postinfection and led to cleavage of poly(ADP-ribose) polymerase, followed by DNA fragmentation and apoptosis. However, the activities of caspases 6 and 7, other important downstream executioners, remained unchanged. Caspase-9 activation was mediated through the mitochondrial pathway of apoptosis, as evidenced by loss of transmembrane potential and cytoplasmic release of cytochrome c. These findings suggest that activation of NF-kappa B is required for maintenance of mitochondrial integrity of host cells and protection against infection-induced apoptotic death by preventing activation of caspase-9- and caspase-8-mediated pathways. Targeted inhibition of NF-kappa B may therefore be exploited to enhance the clearance of infections with R. rickettsii and other intracellular pathogens with similar survival strategies.

Indexed as

ApoptosisCaspase InhibitorsAmino Acid SequenceCaspase 8Caspase 9CaspasesCells, CulturedHumansMitochondriaMolecular Sequence DataNF-kappa BPoly(ADP-ribose) PolymerasesRickettsia rickettsiiRocky Mountain Spotted FeverCASP8 protein, humanCASP9 protein, humanCaspase 8Caspase 9Caspase InhibitorsCaspasesNF-kappa BPoly(ADP-ribose) Polymerases

Identifiers

PMID12819104
PMCPMC162038
OpenAlexW2153053334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.